Skip to content

The Effect of Goal-directed Therapy Guided by Stroke Volume Variation and Cardiac Index in Non-severe Surgical Patients

The Application of Goal-directed Therapy With the Combination of Stroke Volume Variation and Cardiac Index as the Primary Judgment in Non-severe Patients Underwent Gastrointestinal Tumor Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841046
Enrollment
50
Registered
2016-07-21
Start date
2016-07-27
Completion date
2019-06-25
Last updated
2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Therapy

Keywords

stroke volume variation, cardiac index, non-severe patients, gastrointestinal surgery

Brief summary

To evaluate the application of fluid-infusion therapy with the combination of stroke volume variation (SVV) and cardiac index (CI) as the primary judgment in non-severe patients underwent resection of gastrointestinal tumor. Fifty patients (ASA Ⅰ-Ⅱ, 26-55 years old, cardiac functional gradingⅠ) scheduled for gastrointestinal tumor surgery were divided into two groups randomly: group C with CI as the primary judgment and group S with the combination of SVV and CI as the primary judgment.

Detailed description

To evaluate the application of fluid-infusion therapy with the combination of stroke volume variation (SVV) and cardiac index (CI) as the primary judgment in non-severe patients underwent resection of gastrointestinal tumor. Methods: Fifty patients (ASA Ⅰ-Ⅱ, 18-55 years old, cardiac functional gradingⅠ) scheduled for gastrointestinal tumor surgery were divided into two groups randomly: group C with CI as the primary judgment and group S with the combination of SVV and CI as the primary judgment. Patients in group C received a therapy with the goal of CI was no less than 2.5L•min-1•m-2 while SVV was less than 12% and CI was no less than 2.5L•min-1•m-2 in group S. Indexes including MAP、HR、CVP、CI、SVV were recorded at the moment after anaesthetized (T1), when skin was incised (T2), when the intestina was anastomosed (T3) and after the abdomen was closed (T4). SaO2、ScvO2 and plasma lactic were determined at T1 and T4 and DO2,VO2 and ERO2 during the surgery were calculated .The volume of fluid, vasoactive drugs use, the incidence of adverse cardiovascular events, the convalescence of intestinal peristalsis, hospital stay and postoperative complications were recorded.

Interventions

group cardiac index(CI) and group Stroke Volume Variation(SVV) are different treatment schemes of goal-directed fluid therapy guided by SVV and CI,group cardiac index with CI as the primary judgment.

DEVICEStroke Volume Variation

group cardiac index(CI) and group Stroke Volume Variation(SVV) are different treatment schemes of goal-directed fluid therapy guided by SVV and CI,group Stroke Volume Variation with the combination of SVV and CI as the primary judgment.

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical status of grade I-II * Cardiac function classification by NYHA of grade I * without high risk factors according to the revised Lee cardiac risk index: 1. High-risk type of surgery 2. Ischemic heart disease 3. History of congestive heart failure 4. History of cerebrovascular disease 5. Insulin therapy for diabetes 6. Preoperative serum creatinine \> 2.0 mg/dl * undergoing gastrointestinal tumor surgery

Exclusion criteria

* Patients under 18 years or above 55 years * patients with severe aortic regurgitation * patients with permanent cardiac arrhythmias * patients with intra-aortic balloon pump * patients with severe pulmonary disease * patients with hepatic or renal dysfunction * patients undergoing emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Number of Days Needed for Anal Exsufflation After Surgeryup to 8 weeksrecord the number of days needed for anal exsufflation in non-severe patients after gastrointestinal tumor surgery

Secondary

MeasureTime frameDescription
Oxygen Delivery(DO2)during the surgeryoxygen delivery(DO2) in ml•min-1•m-2.Record the data of DO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.
Oxygen Consumption(VO2)during the surgeryoxygen delivery(VO2) in ml•min-1•m-2.Record the data of VO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.
Oxygen Extraction Rate(ERO2)during the surgeryoxygen extraction rate(ERO2) in percentage.Record the data of ERO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.
Number of Days in Hospitalup to 10 weeksThe number of days from the admission to hospital until the discharge from hospital
the Incidence of Adverse Cardiovascular Eventsduring the surgeryincluding hypertension,hypotension,tachycardia,bradycardia

Other

MeasureTime frameDescription
Complication After Surgeryup to 8 weeksFrom the end of surgery to the time of discharge from hospital.including ileus,abdominal infection,infection of incisional wound,pulmonary infection
The Volume of Colloid Infusionduring the surgeryVolume of colloid infusion in milliliter.
The Volume of Crystalloid Infusionduring the surgeryVolume of crystalloid infusion in milliliter.

Participant flow

Participants by arm

ArmCount
Group Cardiac Index
the treatment scheme of goal-directed fluid therapy(GDFT) use cardiac index(CI) as the primary judgment in group cardiac index,Patients in group cardiac index received a therapy with the goal of CI was no less than 2.5L•min-1•m-2 . cardiac index: group cardiac index(CI) and group Stroke Volume Variation(SVV) are different treatment schemes of goal-directed fluid therapy guided by SVV and CI,group cardiac index with CI as the primary judgment.
25
Group Stroke Volume Variation
the treatment scheme of goal-directed fluid therapy(GDFT) use Stroke Volume Variation(SVV)and cardiac index(CI)as the primary judgment in group Stroke Volume Variation,Patients in group Stroke Volume Variation received a therapy with SVV was less than 12% and CI was no less than 2.5L•min-1•m-2 . Stroke Volume Variation: group cardiac index(CI) and group Stroke Volume Variation(SVV) are different treatment schemes of goal-directed fluid therapy guided by SVV and CI,group Stroke Volume Variation with the combination of SVV and CI as the primary judgment.
25
Total50

Baseline characteristics

CharacteristicGroup Stroke Volume VariationTotalGroup Cardiac Index
Age, Continuous39.7 years
STANDARD_DEVIATION 8.3
40.3 years
STANDARD_DEVIATION 8.1
40.9 years
STANDARD_DEVIATION 7.9
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
China
25 participants50 participants25 participants
Sex: Female, Male
Female
8 Participants18 Participants10 Participants
Sex: Female, Male
Male
17 Participants32 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
2 / 251 / 25
serious
Total, serious adverse events
5 / 251 / 25

Outcome results

Primary

Number of Days Needed for Anal Exsufflation After Surgery

record the number of days needed for anal exsufflation in non-severe patients after gastrointestinal tumor surgery

Time frame: up to 8 weeks

ArmMeasureValue (MEAN)Dispersion
Group Cardiac IndexNumber of Days Needed for Anal Exsufflation After Surgery3.8 daysStandard Deviation 1.1
Group Stroke Volume VariationNumber of Days Needed for Anal Exsufflation After Surgery2.7 daysStandard Deviation 1.2
Secondary

Number of Days in Hospital

The number of days from the admission to hospital until the discharge from hospital

Time frame: up to 10 weeks

Secondary

Oxygen Consumption(VO2)

oxygen delivery(VO2) in ml•min-1•m-2.Record the data of VO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.

Time frame: during the surgery

Secondary

Oxygen Delivery(DO2)

oxygen delivery(DO2) in ml•min-1•m-2.Record the data of DO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.

Time frame: during the surgery

Secondary

Oxygen Extraction Rate(ERO2)

oxygen extraction rate(ERO2) in percentage.Record the data of ERO2 at the moment after anaesthetized immediately and at the moment when abdomen was closed.

Time frame: during the surgery

Secondary

the Incidence of Adverse Cardiovascular Events

including hypertension,hypotension,tachycardia,bradycardia

Time frame: during the surgery

Other Pre-specified

Complication After Surgery

From the end of surgery to the time of discharge from hospital.including ileus,abdominal infection,infection of incisional wound,pulmonary infection

Time frame: up to 8 weeks

Other Pre-specified

The Volume of Colloid Infusion

Volume of colloid infusion in milliliter.

Time frame: during the surgery

Other Pre-specified

The Volume of Crystalloid Infusion

Volume of crystalloid infusion in milliliter.

Time frame: during the surgery

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026